Health ❯ Women's Health ❯ Menopause

Hormone Therapy

FDA Regulations Estrogen Therapy Alzheimer's Disease Risk Alzheimer's Disease Alternative Treatments Hormonal Impact on Bladder Health Testosterone Contraception Awareness Local Estrogen Therapy Tirzepatide Bone Health Cognitive Function Breast Cancer Risk Menopause Hormone Therapy Health Risks and Benefits Health Risks Estrogen and Progesterone Risks and Benefits Sexual Health Dementia Risk Treatment Options Personal Experiences

FDA Lifts Broad Black-Box Warnings From Many Menopause Hormone Therapies

The shift reflects newer evidence on age, timing, and formulation, supporting more tailored treatment.

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

FDA Removes Broad Boxed Warnings From Many Menopause Hormone Therapies

Timing of Menopause Hormone Therapy Linked to Divergent Alzheimer’s Risks

Estradiol Therapy Route Tied to Different Memory Skills After Menopause, Study Finds

FDA Begins Expert Review of Menopause Hormone Therapy Warnings